Applying Emerging Therapeutics to Improve and Maintain Quality of Life for Patients with Migraine

Course Information

Therapautic Area: Neurology
Format(s): Slides/Audio
Credit(s): 1.00 AMA PRA Category 1 Credit(s)™
Activity Dates: December 9, 2016 - December 8, 2017


Program Overview

The content for this activity is based on the satellite symposium titled, “Applying Emerging Therapeutics to Improve and Maintain Quality of Life for Patients With Migraine”, that was presented at the Florida Society of Neurology 2016 Annual Meeting. Dr. Teshamae Sereen Monteith from the University of Miami Miller School of Medicine will discuss the pathophysiology of headaches, including prevention and clinical subtypes, as well as recent migraine science. Dr. Monteith will also highlight various disease management strategies along with methods of creating optimal personalized treatment plans. Upon conclusion of this educational activity, healthcare professionals involved in the treatment and management of patients will be equipped with the information needed to improve their practice as it relates to migraine care.


Target Audience

Neurologists, primary care physicians, and other healthcare professionals who care for patients with migraine.


Educational Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the science of migraine headaches, including pathophysiology, clinical subtypes, and the role of prevention.
  2. Review clinical trial data of current and emerging treatment options for the treatment of migraines.
  3. Apply emerging therapeutics to manage patient-specific subtypes and/or symptoms to improve and maintain quality of life for patients with migraine.



screen-shot-2016-12-01-at-11-14-27-amTeshamae Sereen Monteith, MD
Chief of Headache Division
Headache Fellowship Program Director
University of Miami, Miller School of Medicine
Miami, Florida



Disclosure of Conflicts of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:


Faculty                                      Relationship Identified With:
Teshamae Sereen Monteith, MD Consultant/Advisor: Eli Lilly and CompanyGrant/Research Support: Allergan, Inc.
Travel Funds:
Teva PharmaceuticaIndustries Ltd.


Planners, Managers and Reviewers

Timothy Hayes, MD, PhD; Emma Gilmartin and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.


Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Allergan, Inc.


Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Allergan, Inc. do not recommend the use of any agent outside of the labeled indications.



 Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.


CME Inquiries/Special Needs

 For all CME inquiries or special needs, please contact


Provided by AcademicCME screen-shot-2016-12-01-at-11-31-00-am

This activity is supported by an educational grant from Allergan, Inc